eFFECTOR Therapeutics Doses First Patient in Phase 2b KICKSTART Clinical Trial
Clinical trial to assess safety and efficacy of tomivosertib in combination with KEYTRUDA® in patients with non-small cell lung cancerSAN...
Staff
Assembly Biosciences to Present Data from HBV Core Inhibitor Programs at The International Liver Congress™ EASL 2021
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...
PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference
CRANBURY, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
Equillium to Present at the JMP Securities Life Sciences Conference
LA JOLLA, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to...
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences
WOBURN, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized...
USA Equities Corp Announces Co-Promotion Agreement with ENP Network for AllergiEnd® and Upcoming University of Miami CME Workshop
-Further Expanding Independent Practitioner Network and Industry Visibility- West Palm Beach, FL, June 09, 2021 (GLOBE NEWSWIRE) -- USA Equities...
CymaBay Therapeutics Announces Presentations During The International Liver Congress™ 2021
NEWARK, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Starton Therapeutics Advances STAR-LLD Transdermal Lenalidomide Following Successful Skin Permeation Studies
PARAMUS, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care...
Avricore Health Corporate Update Summer 2021
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased...
Applied Molecular Transport to Present at JMP Securities Life Sciences Conference
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...
Kymera Therapeutics to Present New Data Demonstrating both Single-agent and Combination Regressions in MYD88-mutant Lymphoma Preclinical Models with IRAKIMiD Degrader KT-413 at 16th ICML Meeting
Data demonstrate KT-413’s potential as a monotherapy and in combination with rituximab or BTK inhibitors, with potent antitumor activity in...
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting
The market leader in transcranial magnetic stimulation will spotlight real-world clinical data on NeuroStar® Advanced Therapy for Mental HealthMALVERN, Pa.,...
Clover Health to Scale In-home Primary Care Program Through Direct Contracting
Program has driven reductions in hospital stays and medical expensesInks new partnerships with leading home-based care providers, Spiras Health and...
Hepion Pharmaceuticals to be Added to the Russell Microcap® Index
EDISON, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on...
Aleafia Health Establishes At-the-Market Equity Program
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 09, 2021 (GLOBE...
KemPharm to be Added to Russell 2000® and Russell 3000® Indexes Effective June 28, 2021
CELEBRATION, Fla., June 09, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and...
VitalHub Announces Sale to University Hospitals Coventry and Warwickshire NHS Trust
TORONTO, June 09, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the...
Adamis Provides Update on ZIMHI™
FDA Deems New Drug Application for ZIMHI Complete and Establishes a Target Action Date of November 12, 2021SAN DIEGO, June...
Inozyme Announces Acceptance of First European Clinical Trial Application for Phase 1/2 Clinical Trial of INZ-701 in ABCC6 Deficiency
- Clinical trial initiation expected in mid-2021 –- Preliminary safety and biomarker data expected by the end of 2021 -...
OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
ROCKVILLE, Md., June 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power...